| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5912154 | Multiple Sclerosis and Related Disorders | 2016 | 28 Pages |
Abstract
Decreasing the disease activity in multiple sclerosis with immunomodulatory therapy, together with improvements of the diagnostics and treatment of the accompanying depression and fatigue are of high priority to improve the health-related quality of life of patients with multiple sclerosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Zsanett Fricska-Nagy, Judit Füvesi, Csilla Rózsa, Sámuel Komoly, Gábor Jakab, Tünde Csépány, Zita Jobbágy, Gyula Lencsés, László Vécsei, Krisztina Bencsik,